Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 7/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.43 |
| ▸ | QDPR | P09417 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9325871 | 0.85 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DPDGFRB | |
| SCHEMBL9188312 | 0.80 | NR3C1 (0.60) | PDE4APDE4BPDE4CPDE4DNR3C1 | |
| SCHEMBL7723424 | 0.80 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DNR3C1 | |
| SCHEMBL26154148 | 0.78 | MPO (0.44) | PDE4APDE4BPDE4CPDE4DPDGFRB | |
| SCHEMBL1494013 | 0.76 | NR3C1 (0.64) | PDE4APDE4BPDE4CPDE4DNR3C1 | |
| SCHEMBL14492330 | 0.76 | PDE4A (0.49) | PDE4APDE4BPDE4CPDE4DPDGFRB | |
| SCHEMBL7723660 | 0.76 | PDE4B (0.49) | PDE4APDE4BPDE4CPDE4DPDGFRB | |
| SCHEMBL24925906 | 0.75 | SLC6A4 (0.40) | PDE4APDE4BPDE4CPDE4DNR3C1 | |
| SCHEMBL2129892 | 0.75 | PDE4A (0.35) | PDE4APDE4BPDE4CPDE4DNR3C1 | |
| SCHEMBL13063388 | 0.75 | PDE4B (0.49) | PDE4APDE4BPDE4CPDE4DMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658641-A1 | NOVEL COMPOUNDS THAT CAN BE USED AS THERAPEUTIC AGENTS | Xeniom GmbH (DE) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024161041-A1 | NOVEL COMPOUNDS THAT CAN BE USED AS THERAPEUTIC AGENTS | XENIOM GMBH (DE) | 2024-08-08 | — | — | WO | disclosed |